Drugs / BI 1060469
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02438696 | May → Aug 2015 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02202512 | Sep → Dec 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02225626 | Sep → Nov 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02183545 | Jul → Oct 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02126865 | May 2014 → Jul 2015 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01971502 | Oct 2013 → Feb 2014 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 1060469 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02126865 ↗ |
| Route | Oral | “Single Ascending Oral Doses” NCT01971502 ↗ |